Floatz logo

Peripheral Blood Mononuclear Cell

Ischemic Ulcer

Mahidol UniversityCell therapyPhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

7 Active assets in the Ischemic Ulcer cohort.

Asset / SponsorPhaseRating
Cyteal
Charles University, Czech Republic
Phase 4BB
Sevoflurane
Charles University, Czech Republic
Phase 4BB
Oxygen
Jay C. Buckey Jr.
Phase 4BB
Allogeneic Adipose-Derived Mesenchymal Stem Cells
Medical University of Warsaw
Phase 2B
TREPROSTINIL PHOSPHATE
United Therapeutics
Phase 3B

View all 10 →

Same molecule, other indications

Peripheral Blood Mononuclear Cell is also rated in:

Critical Limb IschemiaDormant
BB
Indicative ·
64 / 100
View asset →
atherosclerosisDormant
B
Indicative ·
62 / 100
View asset →
amyotrophic lateral sclerosisDormant
B
Indicative ·
58 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →